Coronado Biosciences to Present at the Upcoming Themes in Helminth Biology Scientific Conference

Published: Aug 20, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., Aug. 20, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Dr. Karin Hehenberger, Coronado's Executive Vice President of Scientific Affairs, will present at the Themes in Helminth Biology Conference on Friday, August 30, 2013, at 8:30 AM EET. Dr. Hehenberger will also be chairing the Helminths and Type 1 Diabetes panel discussion. The conference will be held in Hydra, Greece on August 28-31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news